Hyundai Pharmaceutical Co., Ltd. (KRX:004310)
South Korea · Delayed Price · Currency is KRW 12,020
+670 (5.90%)
Jan 30, 2026, 3:30 PM KST
Hyundai Pharmaceutical Market Cap
Hyundai Pharmaceutical has a market cap or net worth of 332.69 billion as of January 30, 2026. Its market cap has increased by 231.59% in one year.
Market Cap
332.69B
Enterprise Value
n/a
Revenue
108.14B
Ranking
n/a
PE Ratio
199.21
Stock Price
12,020.00
Market Cap Chart
Since August 30, 1995, Hyundai Pharmaceutical's market cap has increased from 28.77B to 332.69B, an increase of 1,056.17%. That is a compound annual growth rate of 8.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 332.69B | 41.08% |
| Dec 30, 2025 | 235.81B | 137.66% |
| Dec 30, 2024 | 99.22B | -12.77% |
| Dec 28, 2023 | 113.76B | -14.20% |
| Dec 29, 2022 | 132.58B | -19.22% |
| Dec 30, 2021 | 164.12B | -22.93% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bukwang Pharmaceutical | 393.18B |
| Yungjin Pharm. | 353.71B |
| BNC Korea | 330.69B |
| Huons | 319.26B |
| CMG Pharmaceutical | 294.50B |
| HLB Pharmaceutical | 293.48B |
| Korea United Pharm | 280.57B |
| Boditech Med | 279.91B |